The Resistance Mechanisms and Treatment Strategies for ALK-Rearranged Non-Small Cell Lung Cancer
Cited by 111
Related Papers
DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application
|Clinical Epigenetics|2021|253
Association between pretreatment emotional distress and immune checkpoint inhibitor response in non-small-cell lung cancer
|Nature Medicine|2024|116
Chronic Stress: Impacts on Tumor Microenvironment and Implications for Anti-Cancer Treatments
|Frontiers in Cell and Developmental Biology|2021|78
Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancers
|Journal for ImmunoTherapy of Cancer|2021|77